ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 185 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $256,000 | -2.3% | 9,111 | -9.7% | 0.00% | – |
| Q4 2020 | $262,000 | -73.7% | 10,087 | -68.1% | 0.00% | -100.0% |
| Q1 2020 | $998,000 | -45.5% | 31,655 | +3.1% | 0.00% | -50.0% |
| Q4 2019 | $1,831,000 | -36.6% | 30,712 | -61.0% | 0.00% | -33.3% |
| Q3 2019 | $2,890,000 | +3.1% | 78,845 | +30.9% | 0.00% | 0.0% |
| Q2 2019 | $2,803,000 | +20.2% | 60,249 | +14.7% | 0.00% | +50.0% |
| Q3 2018 | $2,331,000 | +106.6% | 52,544 | +82.6% | 0.00% | +100.0% |
| Q2 2018 | $1,128,000 | -45.9% | 28,775 | -0.1% | 0.00% | -50.0% |
| Q1 2018 | $2,084,000 | +29.9% | 28,812 | +18.2% | 0.00% | 0.0% |
| Q4 2017 | $1,604,000 | -18.2% | 24,367 | +1.6% | 0.00% | 0.0% |
| Q2 2015 | $1,961,000 | +22.9% | 23,980 | +39.2% | 0.00% | 0.0% |
| Q1 2015 | $1,595,000 | – | 17,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |